Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Under inquiry(Unknown cause of death); This is a spontaneous report from a contactable healthcare professional. A 73-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4237), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included prostatic hyperplasia. The patient''s concomitant medications were not reported. The patient''s circumstance of death was under inquiry on an unspecified date. The patient died on an unspecified date. The cause of death was unknown. It was not reported if an autopsy was done. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The information available in this report is limited, and does not allow a medically meaningful assessment of the case. The event "death" with unknown cause is assessed as related to the suspect drug per company guidance. The case will be re-assessed when relevant information, particularly the cause of death, becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Under inquiry(Unknown cause of death)
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166